Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The burden of childhood and adolescent cancers in North Africa and the Middle East (NAME) region: findings from the Global Burden of Disease study 2019.
Karimi A, Saeedi Moghaddam S, Azadnajafabad S, Esfahani Z, Sharifnejad Tehrani Y, Abbasi-Kangevari M, Shobeiri P, Ghamari SH, Masinaei M, Rezaei N, Shahin S, Rayzan E, Rezaei N, Larijani B, Kompani F. Karimi A, et al. Among authors: rayzan e. BMC Pediatr. 2023 Mar 8;23(1):113. doi: 10.1186/s12887-023-03931-4. BMC Pediatr. 2023. PMID: 36890483 Free PMC article.
Regional and national burden of leukemia and its attributable burden to risk factors in 21 countries and territories of North Africa and Middle East, 1990-2019: results from the GBD study 2019.
Heidari-Foroozan M, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Azadnajafabad S, Esfahani Z, Rezaei N, Nasserinejad M, Rezaei N, Rayzan E, Shokri Varniab Z, Golestani A, Haghshenas R, Kompani F, Larijani B, Farzadfar F. Heidari-Foroozan M, et al. Among authors: rayzan e. J Cancer Res Clin Oncol. 2023 Jul;149(8):4149-4161. doi: 10.1007/s00432-022-04293-7. Epub 2022 Sep 1. J Cancer Res Clin Oncol. 2023. PMID: 36048271
Novel DNMT3B Mutation in a Patient with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome and a Bronchopulmonary Collateral Artery.
Aminorroaya A, Rayzan E, Shahkarami S, Seyedpour S, Zoghi S, Aryan Z, Somekh I, Rohlfs M, Klein C, Esmaeilzadeh H, Rezaei N. Aminorroaya A, et al. Among authors: rayzan e. Endocr Metab Immune Disord Drug Targets. 2023;23(3):410-415. doi: 10.2174/1871530322666220822141722. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35996251
Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient.
Danandeh K, Jabbari P, Rayzan E, Zoghi S, Shahkarami S, Heredia RJ, Krolo A, Shamsian BS, Boztug K, Rezaei N. Danandeh K, et al. Among authors: rayzan e. Endocr Metab Immune Disord Drug Targets. 2022;22(10):1040-1046. doi: 10.2174/1871530322666220407091356. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35392793
29 results